Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered

European Journal of Clinical Pharmacology

Volumn 63, Issue 5, 2007, Pages 457-462

  Minzi, O M S ^a   Gupta, A ^b   Haule, A F ^a   Kagashe, G A B ^a   Massele, A Y ^a   Gustafsson, L L ^c  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b Shelys Pharmaceutical Limited   (Tanzania)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Artesunate; Disposition kinetics; Sulphadoxine pyrimethamine

Indexed keywords

ARTESUNATE; FANSIDAR;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DISTRIBUTION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROOM TEMPERATURE; TABLET;

ADULT; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DRUG COMBINATIONS; DRUG INTERACTIONS; HALF-LIFE; HUMANS; MALARIA, FALCIPARUM; PYRIMETHAMINE; SESQUITERPENES; SULFADOXINE;

EID: 34147129728     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0278-4     Document Type: Article

References (27)

1. Taylor WR, Rigal J, Olliaro PL (2003) Drug resistant falciparum malaria and the use of artesunate-based combinations: focus on clinical trials sponsored by TDR. J Vector Borne Dis 40:65-72
2. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, CATer D, Doumbo OK (1997) Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic pattern of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176:1590-1596
3. Schneider P, Bousema T, Omar S, Gouagna L, Sawa P, Schallig H, Sauerwein R (2006) Submicroscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. Int J Parasitol 36:403-408
4. Mugitu K, Abdulla S, Falk N, Masanja H, FElger I, Mshinda H, Beck Hp, Genton B (2005) Efficacy of sulphadoxine-pyrimethamine in Tanzania after two years as first-line drug for treatment of uncomplicated malaria: assessment protocol and implication of treatment policy strategies. Malar J 4:55
5. Mubyazi GM (2003) The role of Research in changing the firstline antimalarial drug policy in Tanzania. Working Paper. Alliance for Health Policy and Systems Research (AHPSR), Geneva
6. Majori G (2004) Combined antimalarial therapy using artemisinin. Parassitologia 46:85-87
7. Bloland PB (2000) Combination therapy for malaria in Africa: hype or hope? Bull World Health Organ 78:1378-1388
8. Coleman PG, Morel C, Shillcutt S et al (2004) A threshold analysis of the cost-effectiveness of ACTs in sub-Saharan Africa. Am J Trop Med Hyg 71:196-240
9. Olliaro PL, Taylor WR (2004) Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review. J Postgrad Med 50:40-44
10. Ribera E, Pou L, Lopez RM, Crespo M, Falco V, Ocana I, Ruiz I, Pahissa A (2001) Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis. J Acquir Immune Defic Syndr 28:450-453
11. Ridtitid W, Wongnawa M, Mahatthanatrakul W, Raungsri N, Sunbhanich M (2005) Ketoconazole increases plasma concentrations of mefloquine in healthy human. J Clin Pharm Ther 30:285-290
12. Ridtitid W, Wongnawa M, Mahatthanatrakul W, Punyo J, Sunbhanich M (2002) Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers. Clin Pharmacol Ther 72:505-513
13. Karbwang J, Na Bangchang K, Thanavibul A, Back DJ, Bunnag D, Harinasuta T (1994) Pharmacokinetics of mefloquine alone or in combination with artesunate. Bull World Health Organ 72:83-87
14. Elamin SB, Malik EM, Abdelgadir T, Khamiss AH, Mohammed MM, Ahmed ES, Adam I (2005) Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Malar J J 4:41
15. Priotto G, Kabakyenga J, Pinoges L, Ruiz A, Eriksson T, Coussement F, Ngambe T, Taylor WR, Perea W, Guthmann JP, Olliaro P, Legros D (2003) Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial. Trans R Soc Trop Med Hyg 97:325-330
16. Obonyo CO, Ochieng F, Taylor WR, Ochora SA, Mugitu K, Olliaro P, Ter kiile F, Oloo AJ (2003) Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial. Trans R Soc Trop Med Hyg 97:585-591
17. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, Coleman R, Ude JI, Sadiq A, Duraisingh M, Warhurst D, Alloueche A, Targett G, McAdam K, Greenwood B, Walraven G, Olliaro P, Doherty T (2000) Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 355:2080
18. Tjitra E, Suprianto S, Currie BJ, Morris PS, Saunders JR, Anstey NM (2001) Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia. Am J Trop Med Hyg 65:309-317
19. Marquino W, Ylquimiche L, Hermenegildo Y, Palacios AM et al (2005) Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru. Am J Trop Med Hyg 72:568-572
20. Lilja JJ, Kivisto KT, Neuvonen PJ (2000) Duration of effect of grapefruit Juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Clin Pharmacol Ther 68:384-390
21. Bergqvist Y, Hjelm E, Rombo L (1987) Sulphadoxine assay using capillary blood samples dried on filter paper-suitable for monitoring of blood concentration in the field. Ther Drug Monit 9:203-207
22. Minzi OM, Massele AY, Gustafsson LL, Ericsson O ( 2005) Simple and cost-effective liquid chromatographic method for determination of pyrimethamine in whole blood samples dried on filter paper. J Chromatogr B Anal Technol Biomed Life Sci 814:179-183
23. Svensson US, Ashton M (1999) Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br J Clin Pharmacol 48:528-35
24. Zielinska E, Niewiarowski W, Bodalski J, Stanczyk A, Bolanowski W, Rebowski G (1997) Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases. Clin Pharmacol Ther 62:635-642
25. Chanda P, Hawela M, Kango M, Sipilanyambe N (2006) Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia. Malar J 5:75
26. Price RN, Nosten F, Luxemburger C, van Vugt M, Phaipun L, Chongsuphajaisiddhi T, White NJ (1997) Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 91:574-577
27. Adam I, Magzoub M, Osman ME, Khalil IF, Alifrangis M, Elmardi KA (2006) A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine- pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Ann Clin Microbiol Antimicrob 5:18-22